4-Bromo-1-methoxy-2-(3-methoxypropoxy)benzene

We are 4-Bromo-1-methoxy-2-(3-methoxypropoxy)benzene CAS:173336-76-0 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Chemical Name: 4-Bromo-1-methoxy-2-(3-methoxypropoxy)benzene
CAS.NO: 173336-76-0
Synonyms:4-bromo-1-methoxy-2-(3-methoxypropoxy)benzene

Molecular Formula: C11H15BrO3
Molecular Weight: 275.13900

Physical and Chemical Properties:
Density: 1.313g/cm3
Boiling point:308.8ºC at 760 mmHg
Melting point: /
Flash point: 124.4ºC
Refractive index:  1.512

Specification:
Appearance:  White to slight yellow crystalline solid or
solid-liquid mixture, or colorlessto slight yellow transparent liquid.
Identification:Must conform to reference standard
Clarity:No visible insoluble matter
Water:NMT 0.5%
Related substances Individual impurity:NMT 0.2%
Purity:NLT 99.5%

Packing:
 25kg 1 cardboard drum or according to customer specified requirements
Storage:0-6 ° C refrigerated, sealed, dry place, in an inert gas environment.
Application:Intermediates of Aliskiren hemifumarate CAS:173334-58-2.

4-Bromo-1-methoxy-2-(3-methoxypropoxy)benzene


Related News: Genzyme Pharmaceuticals develops and manufactures chemically synthesized pharmaceutical materials and technologies for the global pharmaceutical industry and focuses on lipids, peptides, carbohydrates, oligonucleotides, and custom small molecules.6961-82-6 Genzyme Pharmaceuticals develops and manufactures chemically synthesized pharmaceutical materials and technologies for the global pharmaceutical industry and focuses on lipids, peptides, carbohydrates, oligonucleotides, and custom small molecules.5-Bromo-4-fluoro-2-methylaniline CAS:627871-16-3 FT819 is derived from a clonal master engineered induced pluripotent stem cell (iPSC) line with complete elimination of T-cell receptor (TCR) expression and a novel 1XX CAR targeting CD19 inserted into the T-cell receptor alpha constant (TRAC) locus.5-metil-3H-1,3,4-tiadiazol-2-tiona CAS:29490-19-5 FT819 is derived from a clonal master engineered induced pluripotent stem cell (iPSC) line with complete elimination of T-cell receptor (TCR) expression and a novel 1XX CAR targeting CD19 inserted into the T-cell receptor alpha constant (TRAC) locus.Beneficial drug raw materials refer to the active pharmaceutical ingredients used in the manufacture of original research drugs (patent drugs). They are mainly used to meet the needs of original multinational pharmaceutical companies and emerging biopharmaceutical companies for innovative drugs in clinical drug research, registration approval and commercialization sales , Which also contains advanced intermediates used in the manufacture of the drug substance that need to be regulated by regulatory authorities.

Related Products
Product Name
3-bromo-9-naphthalen-2-ylcarbazole View Details
Allyl bromide View Details
methyl (2R)-2-amino-2-(4-hydroxyphenyl)acetate,hydrochloride View Details
Glabridin manufacturer 4-(Trifluoromethoxy)anisole manufacturer 3,5-DimEthylpyrrole-2,4-Dicarboxylic Acid 2-t-Butyl Ester-4-Ethyl Ester manufacturer 1-Chloro-3-isocyanatobenzene manufacturer 2-chloro-4,6-dinaphthalen-2-yl-1,3,5-triazine manufacturer